Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM)


$5.5400
+0.3400 ( +7.16% ) 68.4K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$5.5400

Previous close


$5.2000

Volume


68.4K

Market cap


$113.85M

Day range


$4.9400 - $5.6100

52 week range


$2.8500 - $8.1100

SEC Filings


Form Type Description Pages Date
def Proxies and info statements 4 Apr 29, 2024
10-k Annual reports 106 Mar 29, 2024
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 25, 2024
4 Insider transactions 1 Mar 25, 2024
4 Insider transactions 1 Mar 25, 2024
8-k 8K-related 15 Mar 21, 2024
4 Insider transactions 1 Feb 23, 2024
8-k 8K-related 14 Jan 02, 2024
4 Insider transactions 1 Dec 08, 2023

Latest News